Survodutide

Original price was: $134.00.Current price is: $107.20.

Member Price: $85.76 Become a member →

Out of stock

...
99%+ purity guaranteed
USA Lab Verified

Become a Member and save 20% on Every Order. 

Become a Member

EMAIL US FOR WHOLESALE PRICING
Orders of $5,000 or more

Description

Description

Survodutide (BI 456906) is a synthetic research peptide characterized as a dual agonist of the glucagon receptor (GCGR) and glucagon-like peptide-1 receptor (GLP-1R). It is a 29–amino acid acylated peptide, incorporating a C18 fatty acid moiety that enhances molecular stability and receptor engagement duration in experimental systems.

In laboratory research settings, Survodutide is studied as a molecular tool for investigating dual-receptor endocrine signaling, energy balance regulation, and integrated metabolic pathway coordination. In cell-based assays, it has demonstrated high-affinity activation of both GCGR and GLP-1R, enabling detailed analysis of receptor crosstalk, signal bias, and downstream intracellular pathway integration under controlled, non-clinical conditions.

Survodutide is supplied exclusively for scientific and laboratory research use. It is not intended for human or veterinary consumption, clinical investigation, diagnostic use, or therapeutic application.

Overview

Chemical Identity & Classification

  • Synthetic dual-receptor peptide agonist

  • Targets GCGR and GLP-1R

  • 29–amino acid acylated peptide with C18 fatty acid modification

Why Researchers Study Survodutide

  • To investigate coordinated GCGR and GLP-1R signaling

  • To study dual-hormone receptor crosstalk and pathway integration

  • To explore the impact of peptide acylation on signaling duration and receptor kinetics

Key Research Systems & Pathways

  • Glucagon receptor–mediated signaling networks

  • GLP-1 receptor–associated pathways

  • cAMP-dependent intracellular signaling cascades

  • Integrated metabolic and endocrine regulation models

Survodutide is synthesized under controlled laboratory conditions to ensure high purity, molecular fidelity, and reproducibility for preclinical research applications.

Research

Mechanism of Action & Pathways

In experimental models, Survodutide is studied for its ability to simultaneously activate GCGR and GLP-1R, both of which are G protein–coupled receptors primarily linked to adenylate cyclase and cAMP signaling. Research focuses on how concurrent receptor engagement influences signal amplitude, duration, and pathway bias, as well as how acylation modifies receptor interaction dynamics.

 

Cellular & Molecular Research

Survodutide is commonly utilized in laboratory studies examining:

  • GCGR and GLP-1R binding affinity and activation kinetics

  • cAMP production and downstream signaling responses

  • Receptor desensitization, internalization, and signaling persistence
    All investigations are conducted in controlled in vitro or biochemical assay environments.

 

Metabolic & Endocrine Signaling Research

Research applications may include:

  • Hormone-regulated energy signaling models

  • Endocrine pathway integration studies

  • Comparative analysis of mono- vs. dual-receptor agonism
    These investigations remain exploratory and mechanistic, without therapeutic interpretation.

 

Experimental Models

  • In vitro receptor-binding and signaling assays

  • Ex vivo endocrine tissue studies

  • Non-clinical in vivo preclinical research models

All use is strictly limited to laboratory research contexts.

FAQ

What is Survodutide used for in research?
Survodutide is used in laboratory research to study dual GCGR and GLP-1 receptor signaling, endocrine pathway integration, and peptide acylation effects on receptor dynamics.

What makes Survodutide structurally distinct?
It is a 29–amino acid peptide modified with a C18 fatty acid, which alters stability and signaling persistence in experimental systems.

Which receptors are studied using Survodutide?
Research focuses on glucagon receptors (GCGR) and GLP-1 receptors (GLP-1R).

Is Survodutide approved for human or clinical use?
No. Survodutide is strictly for research use only and is not intended for human consumption, veterinary use, or clinical application.

How should Survodutide be stored and handled?
Survodutide should be stored and handled according to standard laboratory peptide storage and handling practices to maintain stability and integrity.

Shipping & Delivery

Storage & Handling

All peptides are supplied as sterile, lyophilized powder and are stable when handled correctly.

  • On arrival: Store vials in a cool, dry place away from heat and direct sunlight.
  • Long-term (powder): For optimal longevity, keep lyophilized peptides refrigerated to help maintain integrity.
  • After reconstitution: Use an appropriate research diluent (for example, BAC water). Store the reconstituted solution in the refrigerator and use within 20–30 days for best stability.

Note: Minimize exposure to moisture and repeated freeze–thaw cycles. Follow your institution's safety procedures when handling research materials.

Peak Lab Peptides maintains quality-control processes and routinely performs third-party testing to support purity and identity verification. COAs are available upon request for applicable batches. Documentation may vary depending on production timelines.

We aim to make batch-level documentation available whenever possible. Our goal is to expand COA access across the full catalog as production capacity grows.

All products are for laboratory research use only and are not intended for human consumption.